Raise the Bottom Training & Counseling Services, LLC

Raise the Bottom Training & Counseling Services, LLC was paid $10.76M by Medicaid between Jan 2018 and Nov 2024, across 18 billing codes. Its largest line is G2067, Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) — 47% of everything it billed.

Compared with peers

Next to other Addiction (Substance Use Disorder) Counselor providers in Idaho

Rank by total paid#1 of 20

Median peer was paid$376K

This provider vs. median29×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	11,864	$1.35M
2019	11,819	$1.42M
2020	31,011	$2.81M
2021	5,716	$13K
2022	8,436	$362K
2023	24,027	$3.03M
2024incomplete	19,168	$1.77M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G2067	Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)	47%	26,899	7,224	$5.02M
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	21%	10,432	4,252	$2.27M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	12%	21,879	8,317	$1.29M
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	11%	10,923	4,097	$1.21M
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	5.7%	4,100	1,591	$618K
H0004	Behavioral health counseling and therapy, per 15 minutes	1.3%	3,818	3,355	$142K
H0001	Alcohol and/or drug assessment	<1%	1,888	1,877	$77K
H0003	Alcohol and/or drug screening; laboratory analysis of specimens for presence of alcohol and/or drugs	<1%	1,179	149	$48K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	<1%	523	483	$24K
90791	Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation	<1%	132	131	$13K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	<1%	160	156	$12K
H0020	Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program)	<1%	28,399	957	$10K

6 more codes

93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	966	$6K
86580		<1%	467	$3K
90834	Psychotherapy session, about 45 minutes	<1%	93	$3K
90837	Psychotherapy session, about an hour	<1%	68	$2K
99203	Doctor's office visit, new patient (routine)	<1%	16	$1K
36415	Collection of venous blood by venipuncture	<1%	99	$233.41

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialFERRARESE, COURTNEY (BILLER)